diquafosol has been researched along with Cataract, Membranous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akasaki, Y; Fujimoto, K; Fujio, K; Hirosawa, K; Huang, T; Inomata, T; Iwagami, M; Kuwahara, M; Midorikawa-Inomata, A; Miura, M; Murakami, A; Nagao, M; Nakamura, M; Nojiri, S; Okumura, Y; Shimazaki, J; Sung, J | 1 |
| Choi, W; Cui, L; Lee, HS; Li, Y; Yang, JM; Yoon, KC | 1 |
2 trial(s) available for diquafosol and Cataract, Membranous
| Article | Year |
|---|---|
Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial.
Topics: Cataract; Dry Eye Syndromes; Humans; Hyaluronic Acid; Ophthalmic Solutions; Polyphosphates; Randomized Controlled Trials as Topic; Single-Blind Method; Sodium; Tears; Treatment Outcome; Uracil Nucleotides | 2022 |
Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye.
Topics: Cataract; Cataract Extraction; Cell Count; Conjunctiva; Dry Eye Syndromes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmic Solutions; Polyphosphates; Postoperative Period; Prospective Studies; Treatment Outcome; Uracil Nucleotides | 2018 |